CIK: 0001061768 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 13, 2017
Total Value ($000): $8,023,215 (99.5% shares, 0.5% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LNG | CHENIERE ENERGY INC | 20,726,340 | $933,514 | 11.6% | $57.55 | -23.2% | COM NEW | 16411R208 |
| SYF | SYNCHRONY FINL | 29,295,030 | $909,611 | 11.3% | $23.13 | +5.3% | COM | 87165B103 |
| VSAT | VIASAT INC | 13,158,137 | $846,331 | 10.5% | $61.22 | +3.3% | COM | 92552V100 |
| QRVO | QORVO INC | 9,000,000 | $636,120 | 7.9% | $65.71 | +6.2% | COM | 74736K101 |
| — | ALLERGAN PLC | 2,964,203 | $607,513 | 7.6% | $234.40 | — | SHS | G0177J108 |
| — | COLONY NORTHSTAR INC | 47,905,461 | $601,693 | 7.5% | $12.91 | — | CL A COM | 19625W104 |
| — | TWENTY FIRST CENTY FOX INC | 19,137,469 | $504,846 | 6.3% | $26.78 | — | CL A | 90130A101 |
| AR | ANTERO RES CORP | 23,912,257 | $475,854 | 5.9% | $29.01 | -30.6% | COM | 03674X106 |
| PBF | PBF ENERGY INC | 15,724,175 | $434,144 | 5.4% | $25.25 | -8.3% | CL A | 69318G106 |
| TBPH | THERAVANCE BIOPHARMA INC | 9,309,168 | $318,746 | 4.0% | $26.99 | +21.1% | COM | G8807B106 |
| — | DELL TECHNOLOGIES INC | 3,052,459 | $235,680 | 2.9% | $47.80 | — | COM CL V | 24703L103 |
| — | TWENTY FIRST CENTY FOX INC | 7,384,542 | $190,447 | 2.4% | $27.17 | — | CL B | 90130A200 |
| — | KERYX BIOPHARMACEUTICALS INC | 25,791,678 | $183,121 | 2.3% | $14.16 | — | COM | 492515101 |
| CAH | CARDINAL HEALTH INC | 2,530,000 | $169,308 | 2.1% | $56.48 | -2.6% | COM | 14149Y108 |
| — | EXPRESS SCRIPTS HLDG CO | 2,556,891 | $161,902 | 2.0% | $64.83 | — | COM | 30219G108 |
| — | VERITIV CORP | 3,053,724 | $99,246 | 1.2% | $46.74 | — | COM | 923454102 |
| — | ATARA BIOTHERAPEUTICS INC | 5,359,632 | $88,702 | 1.1% | $31.66 | — | COM | 046513107 |
| MCK | MCKESSON CORP | 500,000 | $76,805 | 1.0% | $146.01 | 0.0% | COM | 58155Q103 |
| — | PARATEK PHARMACEUTICALS INC | 2,394,498 | $60,102 | 0.7% | $29.51 | — | COM | 699374302 |
| — | CHIPMOS TECHNOLOGIES INC | 3,048,295 | $58,893 | 0.7% | $14.11 | — | SPONSORED ADR | 16965P103 |
| — | AMC ENTMT HLDGS INC | 3,565,361 | $52,411 | 0.7% | $14.70 | — | CL A COM | 00165C104 |
| — | GTY TECHNOLOGY HOLDINGS INC | 4,400,000 | $46,024 | 0.6% | $10.50 | — | UNIT 99/99/9999 | G4182A110 |
| — | CENTENNIAL RESOURCE DEV INC | 2,407,153 | $42,086 | 0.5% | $18.10 | — | CL A | 15136A102 |
| CAR | AVIS BUDGET GROUP | 1,036,900 | $39,464 | 0.5% | $24.48 | +30.5% | COM | 053774105 |
| — | FORWARD PHARMA A/S | 6,463,265 | $39,232 | 0.5% | $20.56 | — | SPONSORED ADR | 34986J105 |
| NG | NOVAGOLD RES INC | 9,500,000 | $39,140 | 0.5% | $2.49 | +73.4% | COM NEW | 66987E206 |
| — | THERAVANCE BIOPHARMA INC | 30,000,000 | $37,125 | 0.5% | $1.14 | — | NOTE 3.250%11/0 | 88339KAA0 |
| — | CASCADIAN THERAPEUTICS INC | 8,721,079 | $35,669 | 0.4% | $4.22 | — | COM NEW | 14740B606 |
| — | SABAN CAP ACQUISITION CORP | 2,326,500 | $23,381 | 0.3% | $10.00 | — | COM CL A | 78516C106 |
| — | SILVER RUN ACQUISITION | 2,149,352 | $21,880 | 0.3% | $10.13 | — | COM CL A | 82812A103 |
| RUN | SUNRUN INC | 2,848,082 | $15,807 | 0.2% | $9.81 | -30.5% | COM | 86771W105 |
| COR | AMERISOURCEBERGEN CORP | 188,850 | $15,627 | 0.2% | $64.71 | 0.0% | COM | 03073E105 |
| TMQ | TRILOGY METALS INC NEW | 10,600,758 | $9,976 | 0.1% | $0.57 | +72.0% | COM | 89621C105 |
| — | OREXIGEN THERAPEUTICS INC | 2,226,839 | $4,721 | 0.1% | $3.32 | — | COM NEW | 686164302 |
| — | PIONEER NAT RES CO | 28,895 | $4,263 | 0.1% | $147.53 | — | COM | 723787107 |
| — | SIMPLY GOOD FOODS CO | 1,035,146 | $2,458 | 0.0% | $2.37 | — | *W EXP 07/07/202 | 82900L110 |
| — | SABAN CAP ACQUISITION CORP | 1,163,250 | $1,373 | 0.0% | $0.95 | — | *W EXP 09/21/202 | 78516C114 |